Digital intelligence empowerment, communication and innovation | The 2024 API Continuous Manufacturing Technology Exchange Conference was successfully held, Keyuan Pharma was invited to attend the conference!
Recently, the 2024 API Continuous Manufacturing Technology Exchange Conference was successfully held in Dunhua City, Jilin Province. The conference brought together the wisdom and strength of the industry to jointly discuss the latest development trends, technical hotspots and future prospects, negotiate cooperation and seek common development.
As a leading company in the domestic chemical API segment, Keyuan Pharma (stock code: 301281.SZ) was invited to attend the conference and discussed the latest developments and future trends in API continuous manufacturing technology together with many experts and representatives from government departments, industry associations, research institutes and enterprises.
Recently, the 2024 API Continuous Manufacturing Technology Exchange Conference was successfully held in Dunhua City, Jilin Province. The conference brought together the wisdom and strength of the industry to jointly discuss the latest development trends, technical hotspots and future prospects, negotiate cooperation and seek common development.
As a leading company in the domestic chemical API segment, Keyuan Pharma (stock code: 301281.SZ) was invited to attend the conference and discussed the latest developments and future trends in API continuous manufacturing technology together with many experts and representatives from government departments, industry associations, research institutes and enterprises.
At this exchange meeting, Keyuan Pharma demonstrated its practical experience and strong strength in digital intelligence transformation and continuous manufacturing technology. Hongsheng Jiang, Chairman and President of Keyuan Pharma, delivered a keynote speech entitled "Digitalization and Intelligence Helps the Transformation and Upgrading of the Pharmaceutical Industry" to the conference, sharing Keyuan Manufacturing's initiatives and achievements in promoting digital transformation and developing new quality productivity.
As a high-tech new chemical enterprise, Keyuan Pharma attaches great importance to digital intelligence transformation and upgrading. With smart factories, digital workshops, and unmanned production lines as the development direction, Keyuan Pharma has realized the integrated application of enterprise resource planning, product life cycle management, and supply chain management systems, focusing on lean digital operations. Through technological innovation and management optimization, Keyuan Pharma continuously improves the level and ability of continuous production and implements the concept of digital transformation.
With remarkable digital intelligence upgrade results and outstanding innovation capabilities, Keyuan Pharma was honored to be listed in the "2024 Shandong Chemical Industry Intelligent Transformation Benchmarking Enterprise" of the Shandong Provincial Department of Industry and Information Technology. This is not only an affirmation of Keyuan Pharma's achievements in the field of digital intelligence manufacturing, but also a high recognition of the company's adherence to the path of high-quality development and green and low-carbon development.
In the future, Keyuan Pharma will continue to promote digital intelligence transformation and upgrading, promote the in-depth development of continuous manufacturing technology, set a new benchmark for the high-quality development of the chemical industry, and contribute more wisdom and strength to the progress of Chinese pharmaceutical industry.
